A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin protein. Antisense oligonucleotides (AOs) targeted to trigger excision of an exon bearing a mutant premature stop codon in the DMD transcript have been shown to skip the mutated exon and...

Bibliografski detalji
Glavni autori:	Yin, H, Moulton, H, Betts, C, Seow, Y, Boutilier, J, Iverson, P, Wood, M
Format:	Journal article
Jezik:	English
Izdano:	2009

Slični predmeti

Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
od: Yin, H, i dr.
Izdano: (2010)

Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
od: Gang Han, i dr.
Izdano: (2016-03-01)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
od: Annemieke Aartsma-Rus
Izdano: (2022-12-01)

Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
od: Yin, HF, i dr.
Izdano: (2016)

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
od: Betts, C, i dr.
Izdano: (2018)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.
od: Yin, H, i dr.
Izdano: (2011)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice
od: Yin, H, i dr.
Izdano: (2011)

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
od: HaiFang Yin, i dr.
Izdano: (2020-12-01)

Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
od: Lu Yang, i dr.
Izdano: (2013-01-01)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
od: Lu, Q, i dr.
Izdano: (2003)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
od: Aoki, Y, i dr.
Izdano: (2010)

Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of <it>mdx </it>mice
od: Sirsi Shashank R, i dr.
Izdano: (2008-04-01)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
od: Lu, Q, i dr.
Izdano: (2004)

Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.
od: Yin, H, i dr.
Izdano: (2008)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice
od: Xianjun Gao, i dr.
Izdano: (2015-01-01)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-Deficient mdx Mice
od: Xianjun Gao, i dr.
Izdano: (2020-12-01)

Exon skipping peptide-pmos for correction of dystrophin in mouse models of duchenne muscular dystrophy
od: Betts, C, i dr.
Izdano: (2014)

Increased neointimal thickening in dystrophin-deficient mdx mice.
od: Uwe Rauch, i dr.
Izdano: (2012-01-01)

Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse
od: Glenn Dallérac, i dr.
Izdano: (2011-09-01)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
od: Kane L Greer, i dr.
Izdano: (2014-01-01)

In vivo restoration of dystrophin expression in mdx mice using intra-muscular and intra-arterial injections of hydrogel microsphere carriers of exon skipping antisense oligonucleotides
od: Shani Attias Cohen, i dr.
Izdano: (2022-09-01)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
od: Goyenvalle, A, i dr.
Izdano: (2010)

Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse.
od: Yin, H, i dr.
Izdano: (2010)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
od: Sue Fletcher, i dr.
Izdano: (2012-01-01)

Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model
od: Jiajia Lin, i dr.
Izdano: (2024-07-01)

Muscle regeneration in dystrophin-deficient <it>mdx </it>mice studied by gene expression profiling
od: van Ommen G-JB, i dr.
Izdano: (2005-07-01)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
od: Goyenvalle, A, i dr.
Izdano: (2010)

The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
od: Arpana Sali, i dr.
Izdano: (2013-01-01)

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
od: Yokota, T, i dr.
Izdano: (2012)

Effect of 2-Aminoethoxydiphenyl Borate on the State of Skeletal Muscles in Dystrophin-Deficient mdx Mice
od: Mikhail V. Dubinin, i dr.
Izdano: (2024-12-01)

Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx Mice
od: Ngoc Lu-Nguyen, i dr.
Izdano: (2017-03-01)

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
od: Zhi Yon Charles Toh, i dr.
Izdano: (2016-01-01)

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
od: Baban, D, i dr.
Izdano: (2008)

Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice
od: Timothy M. Moore, i dr.
Izdano: (2020-06-01)

Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
od: Chwalenia, K, i dr.
Izdano: (2022)

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
od: Rafael, J, i dr.
Izdano: (2000)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
od: Goyenvalle, A, i dr.
Izdano: (2012)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
od: Goyenvalle, A, i dr.
Izdano: (2012)

Metabolic remodeling agents show beneficial effects in the dystrophin<it>-</it>deficient <it>mdx</it> mouse model
od: Jahnke Vanessa E, i dr.
Izdano: (2012-08-01)

Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice
Izdano: (2010-01-01)